The awards celebrate professionals who have shown exemplary dedication to protecting the integrity of the supply chain and upholding the highest standards of safety and security in both public and private sectors.
The Good Distribution Practices Accreditation Program aims to support pharmaceutical supply chain stakeholders, especially vendor service providers, in demonstrating compliance with globally recognized GDP operational and training standards.
Healthcare Distribution Alliance chairman on what lies ahead.
Winning companies are selected by the distributor and manufacturer member executives of the HDA Industry Relations Council.
“Matt's leadership, dedication to innovation and commitment to excellence have made him a standout in the healthcare distribution industry."
The latest Factbook reveals that approximately 95 percent of all pharmaceutical sales moved through the traditional distribution segment in 2023, among other key findings.
HDA recently hosted a LinkedIn Live discussion exploring how supply chain stakeholders are working together to tackle these challenges and advocate for solutions.
Pharmaceutical distributor sales reached $758 billion amid some of the lowest profit margins in the study’s 95-year history — 0.3 percent (net after taxes) and 1.7 percent (gross) in 2023.
“HDA and our pharmaceutical distributor members applaud the FDA’s decision to grant an exemption for the DSCSA’s enhanced drug distribution security (EDDS) requirements for eligible trading partners."
